Top 44 Biotech Quotes & Sayings

Biotech crops are not a solution to solve hunger in Africa or elsewhere.

My high-tech aversion caused me to make fun of the typical biotech enterprise: $100 million in cash from selling shares, one hundred Ph.D.'s, 99 microscopes, and zero revenues.

I support GMOs. And we should label them. We should label them because that is the very best thing we can do for public acceptance of agricultural biotech. And we should label them because there's absolutely nothing to hide.

One of the problems in the biotech world is the lack of women in leadership roles, and I'd like to see that change by walking the walk.

I'm an investor in a number of biotech companies, partly because of my incredible enthusiasm for the great innovations they will bring.

Biotech 1.0 is slow, like a lab science, and Version 2.0 is more like computational sciences.

We're at the beginning of the digitization and automation of biotech.

In the biotech revolution, it is the human body, not iron or steel or plastic, that's at the source. Are the biocapitalists going to be allowed to dig without consent into our genetic codes, then market them?

Industries with rapid change are the enemy of the investor. Tech businesses, particularly biotech, is a problem from that point of view. All industries work with change, but you should ideally be investing in businesses with a low rate of change, not a high rate of change.

The really basic stuff that fuels 30-year job booms almost always comes from government research, stuff like biotech, the transistor, the Internet. The idea that private capital can handle the early spade work is a joke.

It's a great disappointment as a leader in the biotech industry that with all the amazing things the drug industry has done in the last couple of decades, we have not made a single major advance, have not not developed a single new chemical entity approved for the treatment for Alzheimer's disease.

IndieBio's capital, facilities, and deep mentoring by a network of biotech-specific experts have the potential to spawn the Google, Facebook, and Instagrams of biology.

We are working with a biotech company, Calypte, which has designed a urine test for the HIV antibody.

Bioscience and biotech offer many opportunities. The U.S. focuses on the rich man; India has rich man diseases and poor man diseases. So you have a much larger set of opportunities.

The first generation of biotech physically cut and pasted from one organism to another. You learned that taxol helped cure cancer, then you found the source organism and extracted the genes to make your drug. Now physical science is becoming information science.

A lot of people said this was impossible. 'You can't build biotech for $50,000. You can't build anything for $50,000.' Well, that's no longer true, and we're proving it.

Biotech and geo engineering have the same mindset, of engineering, of power, of control, of mastery of nature.

I don't think that a mutual fund that invests exclusively in biotech start-ups or invests exclusively in companies in Thailand offers any great safety or diversification.

We need people building companies all over the country to innovate in aviation, consumer products, education, health, cybersecurity, biotech, manufacturing, and everything in between.

The pace of progress in biology creates a foundation that naturally gets picked up by the biotech and pharmaceutical industry to solve rich-world diseases. This is attractive science. It's science that people want to work on.

Biohackers want to tinker; do fun science; and, in the process, accelerate the pace of biotech innovation.

It was a chance encounter with a biotech entrepreneur from Ireland that got me started as an entrepreneur in India, because I partnered this Irish company in setting up India's first biotech company.

The biotech game is quickly changing. The people must demand their use of these treatments.

As we move on into this so-called biotech revolution and we start producing more and more transgenic manipulations, we'll start seeing pieces of DNA interacting with each other in ways that are totally unpredictable I think this is probably the largest biological experiment humanity has ever entered into.

Optimization tells us precisely how to diversify the portfolio, whether I should have 12% in semiconductors or 4% in biotech, etc., and it literally tells me how to diversify not only the industry groups but the stocks.

Business, life itself, is damned hard work if you wanna be good at it. Actually, that's precisely wrong. Business ceases to be work when you're chasing a dream that has engorged you. ("Work should be more fun than fun" - Noel Coward.) And if the passion isn't there. then biotech and plumbing will be equal drags.

I call myself an accidental entrepreneur. I was all set to take up a brewing job in Scotland when a chance encounter with an Irish entrepreneur led me to set up a biotech business in India instead.

The development of exponential technologies like new biotech and AI hint at a larger trend - one in which humanity can shift from a world of constraints to one in which we think with a long-term purpose where sustainable food production, housing, and fresh water is available for all.

The trouble is the field of science, medicine, universities, biotech companies - you name it - have been so splintered, layers, sub-divided, hacked that people can spend their entire career studying one tiny little cog of life.

In San Diego we have a chance to be the dominant hub for nanotech, biotech, life sciences.

One of the things that launched the strength in biotech is when the pharmaceutical industry itself got a little slow.

Researchers and biotech executives foresee the day when the effects of many catastrophic diseases can be reversed. The damaged brains of Alzheimer's disease patients may be restored. Severed spinal cords may be rejoined. Damaged organs may be rebuilt. Stem cells provide hope that this dream will become a reality.

IndieBio's capital, facilities and deep mentoring by a network of biotech specific experts have the potential to spawn the Google's, Facebook's and Instagram's of biology.

Government investment unlocks a huge amount of private sector activity, but the basic research that we put into IT work that led to the Internet and lots of great companies and jobs, the basic work we put into the health care sector, where it's over $30 billion a year in R&D that led the biotech and pharma jobs. And it creates jobs and it creates new technologies that will be productized. But the government has to prime the pump here. The basic ideas, as in those other industries, start with government investment.

Hype tends to precede the reality in biotech, but the reality does follow. Usually.

At this moment, glyphosate is the biggest threat. And because of its overuse, we are seeing the emergence of superweeds, which have grown resistant to glyphosate. This has led to biotech corporations developing even more toxic herbicides, including 2,4-D, one of the main components of Agent Orange.

Martha Stewart denied allegations that she had been given inside information to sell 4,000 shares of a stock in a biotech firm. Stewart then showed her audience how to make a festive, quick-burning yule log out of freshly-shredded financial documents.

Biotech research is incredibly important for health-care innovation.

A decade ago, critics suggested biotech crops would not be valuable in the developing world. Now 90 percent of farmers who benefit are resource-poor farmers in developing countries. These helped alleviate 7.7 million subsistence farmers in China, India, South Africa, the Philippines from abject poverty.

I work in the tech industry and my husband works in biotech. He's head of IP for a company listed on the NASDAQ. And we have a lot of discussions in tech and biotech about the role of unionization in our industries.

When a nanotech company matures and becomes a real business, it becomes something else. It becomes a biotech company or a cleantech company or a memory chip company. Nanotechnology has fueled the core innovations in electronics and energy.

It ended up being a great quarter across the country. The national trend was more on the IT (information technology) side of things. When you look at Southern California and San Diego specifically, it's driven largely by the life sciences and biotech side of things.

The 1st Congressional District contains almost half of the biotech and biomedical companies in Washington, and my job often allows me to meet the people responsible for this exciting research.

What we are saying is, we've got three aluminum factories, let's work with that, we cannot change that. Why not have the Icelandic people who are educated in high-tech and work already in those factories in the higher paid jobs, why not let them build little companies who are totally Icelandic with the knowledge they have? Then they get the money and it stays in the country. Then we can support the biotech companies and the food companies and all these clusters. I think that if you want to be an environmentalist in Iceland, these are the things you've got to be putting your energy into.